Posts tagged “GSK”
Plans for pharmaceutical giants Novartis, GlaxoSmithKline and Eli Lilly to swap business lines may have shaken up the stock market Tuesday, but work at a Novartis flu vaccine plant in Holly Springs hummed along, and local officials said they expect it to remain that way.
GSK's top executive Andrew Witty says the multiple deals announced early Tuesday with Novartis promise to deliver "broadly sustainable sourced sales growth and improve long-term earnings."
Two drug giants with major operations in the Triangle, Novartis and GlaxoSmithKline, are swapping businesses in two major deals. Meanwhile, Novartis plans to sell its huge Holly Springs plant in a separate deal and also strikes an agreement to sell its animal health business to Eli Lilly. No layoffs are planned, Novartis says.
Drug giants Novartis and GlaxoSmithKline each offered investors online presentations that spell out graphically how the deals announced Tuesday will affect each company. Here's a look at three key slides from the Novartis presentation.
Drug giants GlaxoSmithKline and Novartis each offered investors online presentations that spell out graphically how the deals announced Tuesday will affect each company. Here's a look at three key slides from the GSK presentation.
The drug giant issues a statement reiterating it has "zero tolerance for unethical or illegal behavior" and says 48 employees were fired in 2013. The statement comes after reports that bribery probes are underway in two more countries.
The BBC is reporting that pharmaceutical company GlaxoSmithKline is accused of bribing doctors to prescribe medicines in Poland, making this the third country to have an investigation currently ongoing.
Drug giant GlaxoSmithKline said Monday it has launched an investigation into allegations it bribed doctors in Iraq, as the pharmaceuticals giant remains embroiled in a major corruption scandal in China.
"Both Sir Andrew and the board are mindful of the impact this issue has had on the reputation of the company," GSK's chairman says. "As a result, the bonuses awarded for 2013 were lower than they otherwise might have been."
Anoro may help GSK protect its respiratory business, which made up 42 percent of its total pharmaceutical sales last year. The company's top-selling product, Advair for smokers' cough and asthma, is facing increasing competition from a newly approved generic in Europe and cheaper options in the U.S.
Data generated from the work will be made public for other scientists to use, a move that the U.S. National Institutes of Health called groundbreaking. The targeted diseases are some of the most prevalent conditions among Americans, costing the nation billions of dollars in treatment and lost productivity.
The warning is stark: "The danger we face today is the possibility that fewer people will enter highly technical fields in the decades ahead, at a time when demand for individuals with these kinds of skills is on the rise." U.S. student achievement in STEM fields lags many industrialized countries, and North Carolina students lag many states. But pharma companies are stepping in to help bridge the gap. WRALTechWire examines the report from Battelle and its implications for North Carolina as well as the U.S.
RTI partners on epilepsy work; SAS ranked in report; lawyers use cloud tools; Kenan-Flagler dean recommended; Abbott gets new trial
In our Bulldog Blog's latest life sciences and technology update: RTI partners on epilepsy network; SAS makes ranking; lawyers use more cloud tools; Kenan-Flagler dean recommended; AbbVie gets new drug trial.
GlaxoSmithKline says sales in China, where the company faces a bribery probe, have improved since the third quarter when revenue plunged 61 percent from a year earlier. In other news, the CDC affirmed support for rotavirus vaccines that combat severe diarrhea in infants from GSK and Merck.
Good news, bad news for GlaxoSmithKline on Monday: A treatment for metastatic lung cancer receives "Breakthrough Therapy" designation from the FDA. However, GSK also says it has dropped development of a muscular dystrophy treatment.